Management considerations for a heterozygous protein C deficient patient undergoing open heart surgery with cardiopulmonary bypass.
Lawson
D S
DS
Perfusion Services, Department of Pediatrics, Duke University Medical Center, Durham, NC.
Darling
E M
EM
Ware
R E
RE
Kern
F H
FH
Ungerleider
R M
RM
Shearer
I R
IR
D000925:Anticoagulants / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000379:methods*; D002315:Cardiopulmonary Bypass; D002648:Child; D006579:Heterozygote; D006801:Humans; D008297:Male; D010952:Plasma Substitutes / Q000627:therapeutic use; D011486:Protein C / Q000235:genetics; D020151:Protein C Deficiency; D012086:Reoperation; D013771:Tetralogy of Fallot / Q000150:complications / Q000601:surgery*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*